FrancophonIA/ELRC3.0 huggingface dataset:
English: The Committee concluded that given the benefits seen in preventing fractures in patients at high risk, Protelos/Osseor
Slovenian: Odbor je ob upoštevanju koristi, ki so jih opazili pri preprečevanju zlomov pri bolnikih z
English: • Your treatment with Protelos/Osseor will be stopped if you develop heart or circulatory problems during treatment.
Slovenian: • Če se bodo med zdravljenjem z zdravilom Protelos/Osseor pri vas pojavile težave s srcem ali ožiljem, bo zdravnik zdravljenje prekinil.
English: There was also an unvaccinated control group.
Slovenian: V študijo je bila vključena tudi necepljena kontrolna skupina.
English: The European Commission granted a marketing authorisation valid throughout the European Union, for Eryseng Parvo on 8 July 2014.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Eryseng Parvo, veljavno po vsej Evropski uniji, izdala 8. julija 2014.
English: For swine erysipelas two laboratory studies were conducted.
Slovenian: Za svinjsko rdečico sta bili izvedeni dve laboratorijski študiji.
English: The most common side effect (seen in more than 1 in 10 pigs) with Eryseng Parvo is mild to moderate inflammation at the injection site which typically resolves within four days but in some cases may persist for up to 12 days post-vaccination.
Slovenian: Najpogostejši neželeni učinek (opažen pri več kot 1 prašiču od 10) zdravila Eryseng Parvo je blago do zmerno vnetje na mestu injiciranja, ki običajno izzveni v štirih dneh, v nekaterih primerih pa vztraja do 12 dni po cepljenju.
English: The parvovirus study showed that Eryseng Parvo protected 100% of the foetuses whilst 89% of foetuses were mummified in the control group.
Slovenian: Študija s parvovirusom je pokazala, da je zdravilo Eryseng Parvo zaščitilo 100 % fetusov, medtem ko je bilo v kontrolni skupini 89 % fetusov mumificiranih.
English: The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Eryseng Parvo exceed the risks for the approved indication and recommended that Eryseng Parvo be given a marketing authorisation.
Slovenian: Odbor za zdravila za uporabo v veterinarski medicini (CVMP) je zaključil, da so koristi zdravila Eryseng Parvo večje od z njim povezanih tveganj za odobreno indikacijo, in priporočil izdajo dovoljenja za promet z zdravilom Eryseng Parvo.
English: Other information about Eryseng Parvo:
Slovenian: Druge informacije o zdravilu Eryseng Parvo:
English: Eryseng Parvo is available as a suspension for injection.
Slovenian: Zdravilo Eryseng Parvo je na voljo v obliki suspenzije za injiciranje.
English: For porcine parvovirus a laboratory study was conducted involving three groups of 11 gilts (female pigs that have not yet had piglets) vaccinated with different concentrations of porcine parvovirus.
Slovenian: Za prašičjo parvovirozo je bila izvedena laboratorijska študija, ki je vključevala tri skupine po 11 mladic (prašičjih samic, ki še niso prasile), cepljenih z različnimi koncentracijami prašičjega parvovirusa.
English: The second laboratory study involved 15 gilts which were vaccinated according to the basic vaccination schedule with a booster dose six months later.
Slovenian: V drugo laboratorijsko študijo je bilo vključenih 15 mladic, ki so jih cepili v skladu z osnovnim razporedom cepljenja, šest mesecev pozneje pa so prejele še poživitveni odmerek.
English: The first study involved 40 pigs; 30 pigs were vaccinated with two doses, separated by three weeks, while a control group of 10 pigs received placebo (dummy treatment).
Slovenian: V prvi študiji, v katero je bilo vključenih 40 prašičev, je bilo 30 prašičev cepljenih z dvema odmerkoma v presledku treh tednov, kontrolna skupina 10 prašičev pa je prejela placebo (zdravilo brez zdravilne učinkovine).
English: In the future, if the animals are exposed to porcine parvovirus and Erysipelothrix rhusiopathiae bacteria, the immune system will be able to respond more quickly.
Slovenian: Ob morebitni ponovni izpostavitvi prašičjemu parvovirusu in bakteriji Erysipelothrix rhusiopathiae se bo imunski sistem lahko odzval hitreje.
English: Pigs were vaccinated with two doses at an interval of three weeks, with the second dose given three to four weeks before mating.
Slovenian: Cepljene so bile z dvema odmerkoma v presledku treh tednov, pri čemer so drugi odmerek prejele tri do štiri tedne pred parjenjem.
English: The measure of effectiveness was absence of porcine parvovirus and anti-porcine parvovirus antibodies in the foetuses.
Slovenian: Merilo učinkovitosti je bila odsotnost prašičjega parvovirusa in protitelesa proti prašičjemu parvovirusu v fetusih.
English: Eryseng Parvo contains an adjuvant (aluminium hydroxide, DEAE-dextran and ginseng) to enhance the immune response.
Slovenian: Zdravilo Eryseng Parvo vsebuje tudi adjuvans (aluminijev hidroksid, DEAE-dekstran in ženšen) za povečanje imunskega odziva.
English: Pigs were challenged with parvovirus at day 40 of pregnancy and then euthanized (humanely killed) at day 90 of pregnancy.
Slovenian: Samicam so 40. dan brejosti vbrizgali parvovirus, 90. dan brejosti pa so jih evtanazirali (ubili na human način).
English: Eryseng Parvo is a vaccine.
Slovenian: Zdravilo Eryseng Parvo je cepivo.
English: For swine erysipelas, the first laboratory study showed that 90% (27 out of 30) of vaccinated pigs were protected against Erysipelothrix rhusiopathiae serotype 1 remaining free of specific skin lesions whilst 93% (28 out of 30) of vaccinated pigs were protected against Erysipelothrix rhusiopathiae serotype 2 remaining free of specific skin lesions.
Slovenian: Pri svinjski rdečici je prva laboratorijska študija pokazala, da je bilo 90 % (27 od 30) cepljenih prašičev zaščitenih pred serotipom 1 bakterije Erysipelothrix rhusiopathiae, kar pomeni, da se pri njih niso pojavile specifične kožne lezije, pred serotipom 2 bakterije Erysipelothrix rhusiopathiae pa je bilo zaščitenih 93 % (28 od 30) cepljenih prašičev, kar prav tako pomeni, da se pri njih niso pojavile specifične kožne lezije.
English: When Eryseng Parvo is given to pigs the animals' immune system recognises the virus and bacteria as ‘foreign' and makes antibodies against them.
Slovenian: Ko prašiče cepimo z zdravilom Eryseng Parvo, njihov imunski sistem virus in bakterije prepozna kot „tujke“ in proti njim razvije protitelesa.
English: Porcine parvovirus causes infertility, still births and small litters in sows (female pigs that have had piglets).
Slovenian: Prašičji parvovirus povzroča neplodnost, mrtvorojenost in majhna legla pri svinjah (prašičjih samicah, ki so že prasile).
English: What benefit has Eryseng Parvo shown during the studies?
Slovenian: Kakšne koristi je zdravilo Eryseng Parvo izkazalo med študijami?
English: Eryseng Parvo is a veterinary vaccine that contains inactivated (killed) porcine parvovirus and Erysipelothrix rhusiopathiae bacteria.
Slovenian: Zdravilo Eryseng Parvo je cepivo za uporabo v veterinarski medicini, ki vsebuje inaktivirana (uničena) prašičji parvovirus in bakterijo Erysipelothrix rhusiopathiae.
English: It contains a strain of porcine parvovirus called NADL-2 and a strain of Erysipelothrix rhusiopathiae called R32E11.
Slovenian: Vsebuje sev prašičjega parvovirusa NADL-2 in sev bakterije Erysipelothrix rhusiopathiae R32E11.
English: This will help protect them against porcine parvovirus and swine erysipelas.
Slovenian: To bo pripomoglo k zaščiti prašičev pred prašičjo parvovirozo in svinjsko rdečico.
English: The second laboratory study showed 93% (14 out of 15) pigs were protected against challenge with Erysipelothrix rhusiopathiae serotypes 1 and 2.
Slovenian: Druga laboratorijska študija je pokazala, da je bilo 93 % (14 od 15) samic zaščitenih pred serotipoma 1 in 2 bakterije Erysipelothrix rhusiopathiae.
English: Eryseng Parvo is also used to protect male and female pigs against swine erysipelas caused by Erysipelothrix rhusiopathiae, serotype 1 and serotype 2.
Slovenian: Zdravilo Eryseng Parvo se uporablja tudi za zaščito prašičjih samcev in samic pred svinjsko rdečico, ki jo povzroča bakterija Erysipelothrix rhusiopathiae serotipa 1 in serotipa 2.
English: What is the risk associated with Eryseng Parvo?
Slovenian: Kakšna tveganja so povezana z zdravilom Eryseng Parvo?
English: Porcine parvovirosis and swine erysipelas vaccine (inactivated)
Slovenian: cepivo proti prašičji parvovirozi in svinjski rdečici (inaktivirano)
English: Eryseng Parvo is used to protect embryonic and foetal (unborn) piglets against porcine parvovirus infection via the placenta.
Slovenian: Zdravilo Eryseng Parvo se uporablja za zaščito prašičjih zarodkov in fetusov (nerojenih pujskov) pred okužbo s prašičjim parvovirusom prek posteljice.
English: Why has Eryseng Parvo been approved?
Slovenian: Zakaj je bilo zdravilo Eryseng Parvo odobreno?
English: The withdrawal period for Eryseng Parvo is zero days.
Slovenian: Karenca za zdravilo Eryseng Parvo je nič dni.
English: What is Eryseng Parvo used for?
Slovenian: Za kaj se zdravilo Eryseng Parvo uporablja?
English: How has Eryseng Parvo been studied?
Slovenian: Kako je bilo zdravilo Eryseng Parvo raziskano?
English: What is Eryseng Parvo?
Slovenian: Kaj je zdravilo Eryseng Parvo?
English: How does Eryseng Parvo work?
Slovenian: Kako zdravilo Eryseng Parvo deluje?
English: Velmetia is taken twice a day.
Slovenian: Zdravilo Velmetia se jemlje dvakrat na dan.
English: The European Commission granted a marketing authorisation valid throughout the EU for Velmetia on 16 July 2008.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Velmetia, veljavno po vsej Evropski uniji, odobrila dne 16. julija 2008.
English: The full EPAR for Velmetia can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Velmetia je na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: This is a summary of the European public assessment report (EPAR) for Velmetia.
Slovenian: To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Velmetia.
English: Other information about Velmetia
Slovenian: Druge informacije o zdravilu Velmetia
English: It must also not be used in patients who consume excessive amounts of alcohol or who are alcoholic, or in women who are breast-feeding.
Slovenian: Prav tako se ne sme uporabljati pri bolnikih, ki prekomerno uživajo alkohol ali so alkoholiki, ali pri doječih ženskah.
English: For more information about treatment with Velmetia, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravilom Velmetia preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte z zdravnikom ali farmacevtom.
English: Velmetia sitagliptin / metformin hydrochloride
Slovenian: Velmetia sitagliptin/metforminijev klorid
English: The most common side effect with Velmetia (seen in between 1 and 10 patients in 100) is nausea (feeling sick).
Slovenian: Najpogostejši neželeni učinek zdravila Velmetia (opažen pri 1 do 10 bolnikih od 100) je navzeja (slabost).
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Velmetia.
Slovenian: Pojasnjuje, kako je Odbor za zdravila za uporabo v humani medicini (CHMP) ocenil zdravilo Velmetia, na podlagi česar je oblikoval mnenje za odobritev dovoljenja za promet z njim in priporočila glede pogojev njegove uporabe.
English: What benefit has Velmetia shown during the studies?
Slovenian: Kakšne koristi je zdravilo Velmetia izkazalo med študijami?
English: The CHMP decided that Velmetia's benefits are greater than its risks and recommended that it be given marketing authorisation.
Slovenian: CHMP je zaključil, da so koristi zdravila Velmetia večje od z njim povezanih tveganj, in priporočil, da se zanj odobri dovoljenje za promet.
English: The results of three further studies were used to support the use of Velmetia.
Slovenian: V podporo uporabi zdravila Velmetia so bili uporabljeni rezultati treh nadaljnjih študij.
English: If Velmetia is taken with a sulphonylurea or insulin, the dose of the sulphonylurea or insulin may need to be lowered, to avoid hypoglycaemia (low blood sugar levels).
Slovenian: Če se zdravilo Velmetia jemlje skupaj s sulfonilsečnino ali insulinom, bo morda treba odmerek sulfonilsečnine ali insulina zmanjšati, da ne bi prišlo do hipoglikemije (nizke ravni sladkorja v krvi).
English: Velmetia must not be used in people who are hypersensitive (allergic) to sitagliptin, metformin or any of the other ingredients.
Slovenian: Zdravila Velmetia ne smejo uporabljati osebe, ki so preobčutljive za (alergične na) sitagliptin, metformin ali katero koli drugo sestavino zdravila.
English: The company carried out additional studies to show that the active substances in Velmetia are absorbed by the body in the same way as the two medicines given separately.
Slovenian: Družba je opravila še nadaljnje študije, da bi dokazala, da telo zdravilni učinkovini zdravila Velmetia absorbira na enak način, kot če sta vzeti v obliki ločenih zdravil.
English: Velmetia is a medicine that contains two active substances, sitagliptin and metformin hydrochloride.
Slovenian: Velmetia je zdravilo, ki vsebuje dve zdravilni učinkovini, sitagliptin in metforminijev klorid.
English: Velmetia should be taken with food to avoid any stomach problems caused by metformin.
Slovenian: Zdravilo Velmetia je treba jemati sočasno s hrano, da se preprečijo želodčne težave, ki jih povzroča metformin.
English: What is the risk associated with Velmetia?
Slovenian: Kakšna tveganja so povezana z zdravilom Velmetia?
English: Velmetia is used in patients with type 2 diabetes to improve the control of blood glucose (sugar) levels.
Slovenian: Zdravilo Velmetia se uporablja za zdravljenje bolnikov s sladkorno boleznijo tipa 2 za izboljšanje nadzora nad ravnmi glukoze (sladkorja) v krvi.
English: For the full list of all side effects reported with Velmetia, see the package leaflet.
Slovenian: Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila Velmetia, glejte navodilo za uporabo.
English: The first included 1,091 patients who were not satisfactorily controlled on diet and exercise alone and compared the effect of Velmetia with that of metformin or sitagliptin alone.
Slovenian: V prvo je bilo vključenih 1 091 bolnikov, pri katerih zadosten nadzor ni bil dosežen zgolj z dieto in telesno vadbo, v njej pa so primerjali učinke zdravila Velmetia z učinki metformina ali sitagliptina, uporabljenih kot samostojni zdravili.
English: In the first of the three further studies, Velmetia was more effective than metformin or sitagliptin alone.
Slovenian: V prvi od treh dodatnih študij je bilo zdravilo Velmetia učinkovitejše od metformina ali sitagliptina, uporabljenih kot samostojni zdravili.
English: Why has Velmetia been approved?
Slovenian: Zakaj je bilo zdravilo Velmetia odobreno?
English: The active substances in Velmetia, sitagliptin and metformin hydrochloride, each have a different mode of action.
Slovenian: Zdravilni učinkovini v zdravilu Velmetia, sitagliptin in metforminijev klorid, imata različna načina delovanja.
English: Velmetia was more effective than metformin alone.
Slovenian: Zdravilo Velmetia je bilo učinkovitejše od metformina, uporabljenega kot samostojno zdravilo.
English: The company presented the results of three studies of Januvia/Xelevia to support the use of Velmetia in patients who were not satisfactorily controlled on their existing metformin treatment.
Slovenian: Družba je v podporo uporabi zdravila Velmetia pri bolnikih, pri katerih obstoječe zdravljenje z metforminom bolezni ni zadostno za nadzor bolezni, predstavila rezultate treh študij z zdraviloma Januvia in Xelevia.
English: What is Velmetia used for?
Slovenian: Za kaj se zdravilo Velmetia uporablja ?
English: How does Velmetia work?
Slovenian: Kako zdravilo Velmetia deluje?
English: How has Velmetia been studied?
Slovenian: Kako je bilo zdravilo Velmetia raziskano?
English: How is Velmetia used?
Slovenian: Kako se zdravilo Velmetia uporablja?
English: What is Velmetia?
Slovenian: Kaj je zdravilo Velmetia?
English: Ref.: EMEA/264546/2009 EMEA/H/C/770
Slovenian: : EMEA/264546/2009 EMEA/H/C/770
English: The European Commission granted a marketing authorisation valid throughout the European Union for Avamys to Glaxo Group Ltd on 11 January 2008.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Avamys, veljavno po vsej Evropski uniji, odobrila družbi Glaxo Group Ltd dne 11. januarja 2008.
English: To get the most benefit from the medicine, it should be used regularly and at the same time every day.
Slovenian: Največji učinek zdravila dosežemo, če zdravilo uporabljamo redno in vsak dan ob istem času.
English: Similar results were seen in children aged six years and above.
Slovenian: Podobni rezultati so bili ugotovljeni pri otrocih, starih šest let in več.
English: Avamys fluticasone furoate EPAR summary for the public
Slovenian: Avamys flutikazon furoat Povzetek EPAR za javnost
English: Other information about Avamys:
Slovenian: Druge informacije o zdravilu Avamys:
English: The effects of Avamys were first tested in experimental models before being studied in humans.
Slovenian: Učinki zdravila Avamys so bili najprej preskušeni na poskusnih modelih, nato pa so jih raziskali pri ljudeh.
English: However, it was not possible to determine if Avamys worked in children below the age of six years, because there were too few children below this age included the studies.
Slovenian: Ni pa bilo mogoče ugotoviti, ali je zdravilo Avamys delovalo tudi pri otrocih, starih manj kot šest let, ker je bilo v študije vključenih premalo otrok iz te starostne skupine.
English: This leads to a reduction the release of substances that are involved in the inflammation process, such as histamine, reducing the symptoms of allergy.
Slovenian: Posledica tega je zmanjšano sproščanje snovi, ki sodelujejo v vnetnem procesu, kot je histamin, kar privede do zmanjšanja simptomov alergije.
English: It usually starts to work from eight hours after the first spray, but it may take several days to get the maximum benefit.
Slovenian: Zdravilo običajno začne delovati po osmih urah po prvi uporabi, vendar pa se največji učinek lahko pokaže šele nekaj dni po začetku zdravljenja.
English: It works in a similar way to naturally occurring corticosteroid hormones, reducing the activity of the immune system by attaching to receptors in various types of immune cell.
Slovenian: Ta deluje na podoben način kot naravno prisotni kortikosteroidni hormoni, in sicer tako, da z vezavo na receptorje različnih imunskih celic zmanjšuje delovanje imunskega sistema.
English: The Committee recommended that Avamys be given marketing authorisation.
Slovenian: Odbor je priporočil, da se za zdravilo Avamys odobri dovoljenje za promet.
English: The lowest effective dose that keeps symptoms controlled should be used.
Slovenian: Uporabiti je treba najmanjši odmerek, ki še nadzoruje simptome.
English: The most common side effect with Avamys (seen in more than 1 patient in 10) is epistaxis (nosebleeds).
Slovenian: Najpogostejši neželeni učinek zdravila Avamys (opažen pri več kot 1 bolniku izmed 10) je epistaksa (krvavitve iz nosu).
English: The active substance in Avamys, fluticasone furoate, is a corticosteroid.
Slovenian: Zdravilna učinkovina v zdravilu Avamys, flutikazon furoat, je kortikosteroid.
English: This is generally mild or moderate and tends to affect adults who have used Avamys for more than six weeks.
Slovenian: Te so ponavadi blage do zmerne in so pogostejše pri odraslih, ki so uporabljali zdravilo Avamys več kot šest tednov.
English: What benefit has Avamys shown during the studies?
Slovenian: Kakšne koristi je zdravilo Avamys izkazalo med študijami?
English: Avamys was compared with placebo (a dummy treatment) in six main studies involving almost 2,500 patients.
Slovenian: Zdravilo Avamys so primerjali s placebom (zdravilom brez zdravilne učinkovine) v šestih glavnih študijah, v katere je bilo vključenih skoraj 2 500 bolnikov.
English: Avamys should only be used for as long as the patient is exposed to the allergen, such as pollen, house dust mites or other animals.
Slovenian: Zdravilo Avamys se lahko uporablja samo, dokler je bolnik izpostavljen alergenom, kot so cvetni prah, hišne pršice in druge živali.
English: The recommended dose of Avamys for patients aged 12 years and over is two sprays in each nostril once a day.
Slovenian: Priporočeni odmerek zdravila Avamys pri bolnikih, starih 12 let in več, je dva vpiha v vsako nosnico enkrat dnevno.
English: The other two studies were carried out in children aged between two and 11 years: the first involved 558 children with perennial allergic rhinitis and the second involved 554 children with seasonal allergic rhinitis.
Slovenian: Preostali dve študiji sta bili opravljeni pri otrocih, starih od dve do 11 let: v prvo študijo je bilo vključenih 558 otrok s celoletnim alergijskim rinitisom, v drugo pa 554 otrok s sezonskim alergijskim rinitisom.
English: This is inflammation of the nasal passages caused by an allergy, resulting in runny nose, blocked nose, itching and sneezing.
Slovenian: To je vnetje nosne votline, ki ga povzroči alergija in ima za posledico izcedek iz nosu, zamašen nos, srbenje in kihanje.
English: What is the risk associated with Avamys?
Slovenian: Kakšna tveganja so povezana z zdravilom Avamys?
English: For the full list of all side effects reported with Avamys, see the Package Leaflet.
Slovenian: Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila Avamys, glejte navodilo za uporabo.
English: For children between six and 12 years of age, the recommended dose is one spray in each nostril once a day, although this can be increased to two sprays if symptoms are not controlled.
Slovenian: Pri otrocih, starih med šest in 12 let, je priporočeni odmerek en vpih v vsako nosnico enkrat dnevno, če pa s tem odmerkom ne moremo vzpostaviti nadzora nad simptomi, ga lahko zvišamo na dva vpiha.
English: Avamys should not be used in people who are allergic to fluticasone furoate or any of the other ingredients.
Slovenian: Zdravila Avamys ne smejo uporabljati osebe, ki utegnejo biti preobčutljive za (alergične na) flutikazon furoat ali katero koli drugo sestavino zdravila.
English: It is often accompanied by symptoms affecting the eyes, such as irritation, watering or redness.
Slovenian: Spremljajo ga simptomi, ki prizadenejo oči, kot je draženje, solzenje ali pordelost.
English: Avamys is used to treat the symptoms of allergic rhinitis.
Slovenian: Zdravilo Avamys se uporablja za zdravljenje simptomov alergijskega rinitisa.
English: In the studies of seasonal allergic rhinitis in patients aged 12 years or over, Avamys reduced symptom scores from around 9 points at the start of the study by between 3.6 and 5.4 points over two weeks, compared with a reduction of 2.3 to 3.7 points with placebo.
Slovenian: V študijah sezonskega alergijskega rinitisa pri bolnikih, starejših od 12 let, je zdravilo Avamys v dveh tednih za 3,6 do 5,4 točke zmanjšalo izhodiščno vrednost simptomov, ki je znašala približno 9 točk, v primerjavi z zmanjšanjem za 2,3 do 3,7 točke pri placebu.
English: In the study of perennial allergic rhinitis, Avamys had reduced scores by 3.6 points after four weeks, compared with a reduction of 2.8 points with placebo.
Slovenian: V študiji celoletnega alergijskega rinitisa je zdravilo Avamys po štirih tednih zmanjšalo vrednosti za 3,6 točke v primerjavi z zmanjšanjem za 2,8 točke pri placebu.
English: Avamys is for use in patients aged six years and over.
Slovenian: Zdravilo Avamys se uporablja pri bolnikih, starih šest let in več.